Further, several lines of research confirm dysregulation of NF-κB in Alzheimer's disease (AD), a disorder characterized clinically by a profound deficit in the ability to form new memories. The gene discussed is NFKB1; the disease is early-onset autosomal dominant Alzheimer disease.